Mesothelioma News

Fujirebio Diagnostics Honored with Pioneer Award from MARF; Company Recognized for Substantial Contributions t
Business Wire - for Substantial Contributions to Mesothelioma Research And the MESOMARK on Malignant Mesothelioma, received the award for substantial contributions to mesothelioma research and

Fujirebio Diagnostics Honored with Pioneer Award from MARF
Business Wire via Yahoo! - Pioneer Award from the Mesothelioma Applied Research Foundation (MARF on Malignant Mesothelioma, received the award for substantial contributions to mesothelioma research and

Alfacell (ACEL) To Present At Rodman And Renshaw Techvest 7th Annual Healthcare Conference
BioSpace - studies, including a Phase IIIb registration study for malignant mesothelioma (MM) and a Phase I / II trial in Non

Insurance firm in court bid to halt payouts for asbestos victims
Yorkshire Post - to asbestos, which itself carries an increased risk of malignant disease such as the deadly cancer mesothelioma.